Daily Newsletter

28 September 2023

Daily Newsletter

28 September 2023

Laminate’s VasQ fistula device receives FDA approval 

The device was approved based on a De Novo review of the VasQ US pivotal study, which involved 144 patients.

RanjithKumar Dharma September 28 2023

Laminate Medical Technologies has obtained approval from the US Food and Drug Administration (FDA) for its VasQ External Vascular Support device to be used for creating arteriovenous fistulas for dialysis access.

It is a nitinol-based device designed to implant around the artery and vein during the surgical creation of an arteriovenous fistula.

Designated by the regulator as a breakthrough technology, the device was approved based on a De Novo assessment of the VasQ US pivotal study, which involved 144 patients.

In the VasQ US study, the device attained the primary endpoint of enhanced primary patency at six months. It was also supported by its effectiveness and safety of use in several studies from outside the US.

The device is intended for offering structural reinforcement to the mobilised vessels that are freed from their native supporting tissue, as well as guiding a more stable arterial flow profile as it transitions into the vein.

Furthermore, MRI and computational fluid dynamic models have supported VasQ's proposed mechanistic benefits, with consistent beneficial clinical results in several studies.

Laminate CEO Tammy Gilon said: “We are excited to finally bring VasQ to the US dialysis patient population.

“We could not be more appreciative of our US principal investigators as well as the global community of dialysis access physicians that saw the potential in VasQ and produced the wealth of data supporting the devices safety and effectiveness.”

Generative AI set to transform the medical devices industry

Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close